Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology reports developments in digital orthodontics and restorative dentistry through its Invisalign System of clear aligners, iTero intraoral scanners, exocad CAD/CAM software and the Align Digital Platform. Company news commonly covers product and workflow updates for clear-aligner treatment planning, intraoral scanning, 3D visualization and digitally connected dental practices.
Recurring updates also include quarterly and annual operating results, clear-aligner shipment and channel trends, regional demand, foreign-exchange effects, stock repurchase activity, financial-conference participation and governance or shareholder-voting matters. Other announcements describe clinical education, professional collaborations and access-to-care initiatives involving orthodontists, general practitioner dentists and dental research organizations.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Align Technology (ALGN) reported robust Q1'23 financial results, achieving $943.1 million in total revenues, a 4.6% sequential increase but a 3.1% decline year-over-year. Clear Aligner revenues reached $789.8 million, up 7.9% sequentially, though down 2.5% year-over-year. Operating income was $133.5 million with a 14.2% operating margin. The company completed a $1 billion stock repurchase program and authorized a new $1 billion program. Align treated over 15 million global Invisalign patients and reported a net income of $87.8 million, or $1.14 per diluted share. For Q2'23, the anticipated revenue range is $980 million to $1,000 million, with expectations of improved Clear Aligner volume and ASP.